Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-16-024957
Filing Date
2016-08-11
Accepted
2016-08-11 16:26:28
Documents
1
Effectiveness Date
2016-08-11

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-16-024957.paper CERTNAS 294
  Complete submission text file 9999999997-16-024957.txt   1391
Mailing Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: CERTNAS | Act: 34 | File No.: 001-37853 | Film No.: 16004402
SIC: 2834 Pharmaceutical Preparations